Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial
- 28 September 2017
- Vol. 67 (12), 2156-2168
- https://doi.org/10.1136/gutjnl-2017-314634
Abstract
Objective Limited data are available on the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis (PVT). This study aimed to compare transjugular intrahepatic portosystemic shunt (TIPS) with covered stents versus endoscopic band ligation (EBL) plus propranolol for the prevention of variceal rebleeding among patients with cirrhosis and PVT. Design Consecutive cirrhotic patients (94% Child-Pugh class A or B) with PVT who had variceal bleeding in the past 6 weeks were randomly assigned to TIPS group (n=24) or EBL plus propranolol group (EBL+drug, n=25), respectively. Primary endpoint was variceal rebleeding. Secondary endpoints included survival, overt hepatic encephalopathy (OHE), portal vein recanalisation and rethrombosis, other complications of portal hypertension and adverse events. Results During a median follow-up of 30 months in both groups, variceal rebleeding was significantly less frequent in the TIPS group (15% vs 45% at 1 year and 25% vs 50% at 2 years, respectively; HR=0.28, 95% CI 0.10 to 0.76, p=0.008), with a significantly higher portal vein recanalisation rate (95% vs 70%; p=0.03) and a relatively lower rethrombosis rate (5% vs 33%; p=0.06) compared with the EBL+drug group. There were no statistically significant differences in survival (67% vs 84%; p=0.152), OHE (25% vs 16%; p=0.440), other complications of portal hypertension and adverse events between groups. Conclusion Covered TIPS placement in patients with PVT and moderately decompensated cirrhosis was more effective than EBL combined with propranolol for the prevention of rebleeding, with a higher probability of PVT resolution without increasing the risk of OHE and adverse effects, but this benefit did not translate into improved survival. Trial registration number ClinicalTrials.gov: NCT01326949.Keywords
Funding Information
- Optimized Overall Project of Shaanxi Province
- Boost Program of Xijing Hospital
This publication has 49 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Vascular diseases of the liverJournal of Hepatology, 2015
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- UK guidelines on the management of variceal haemorrhage in cirrhotic patientsGut, 2015
- Management of portal vein thrombosis in liver cirrhosisNature Reviews Gastroenterology & Hepatology, 2014
- Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligationDigestive and Liver Disease, 2014
- The Effectiveness of Current Acute Variceal Bleed Treatments in Unselected Cirrhotic Patients: Refining Short-Term Prognosis and Risk FactorsThe American Journal of Gastroenterology, 2012
- Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2012
- Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein ThrombosisClinical Gastroenterology and Hepatology, 2012
- Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosisLiver International, 2012
- Management of Varices and Variceal Hemorrhage in CirrhosisThe New England Journal of Medicine, 2010